Watchlist
Angle Plc (AGL.L) Announced that the first phase of its ovarian cancer clinical verification study has reported positive results. The pre-study results demonstrate that the optimisation of the sample-to-answer molecular solution has been successful, paving the way to initiate the 200 subject ovarian cancer clinical verification study of patients who are presenting with a pelvic mass and scheduled for surgery. This study is expected to start in early Q3 CY19 and is projected to complete in Q1 CY20.
info
Login or register to post comments